You are here: Industry Insights > Zydus Cadila

News List

Centre places purchase order for one crore doses of Zydus Cadila’s needle-free COVID vaccine ExpressPharma
November 09, 2021
Zydus Cadila’s three-dose COVID vaccine ZyCoV-D is set to be included in the national anti-coronavirus inoculation programme this month with the Centre placing a purchase order...
Zydus Cadila receives final approval from US FDA for Fulvestrant injection expresspharma
August 02, 2021
The drug will be manufactured at the group’s formulation manufacturing facility at Zydus Biologics, Ahmedabad.
Zydus Cadila receives tentative approval from USFDA for Ibrutinib expresspharma
July 23, 2021
The drug will be manufactured at the group’s formulation manufacturing facility at the Special Economic Zone (SEZ), Ahmedabad.
Working with Moderna to see make its COVID vaccine available in India: Govt expresspharma
July 12, 2021
The government said that it is working actively with COVID-19 vaccine manufacturer Moderna to see how its vaccine can be imported and made available in the country.
Zydus Cadila gets USFDA approval for Fluphenazine Hydrochloride Tablets expresspharma
May 31, 2021
This medication is used to treat symptoms of a certain type of mental/mood condition (schizophrenia).
Virafin from Zydus Cadila priced at Rs 11,995 per dose expresspharma
May 12, 2021
The company has commenced dispatching the drug which can reportedly reduce oxygen support in COVID-19 patients, as per reports.
Zydus Cadila gets final US FDA approval for Propafenone Hydrochloride ER capsules expresspharma
April 25, 2021
Zydus Cadila has received final approval from the USFDA to market Propafenone Hydrochloride Extended-Release Capsules USP, 225 mg, 325 mg, and 425 mg (US RLD: Rythmol Capsules). Propafenone is known as an anti-arrhythmic drug.
Zydus Cadila gets EUA from DCGI for hepatitis drug Virafin to treat COVID-19 expresspharma
April 25, 2021
Zydus Cadila has received restricted emergency use approval from the DCGI for the use of Pegylated Interferon alpha-2b (PegIFN) in treating moderate COVID-19 infection in adults.
Efforts to ramp up production of COVID-19 vaccines, easy availability underway: Renu Swarup expresspharma
April 23, 2021
The regulators have also permitted manufacturing at risk and stockpiling doses even before approval so that they can be rolled out into the immunisation programme without any time lag, she said.
Zydus Cadila gets final US FDA approval for Nortriptyline Hydrochloride Capsules expresspharma
February 26, 2021
Zydus Cadila has received final approval from the USFDA to market Nortriptyline Hydrochloride Capsules USP, 10 mg, 25 mg, 50 mg and 75 mg (US RLD: Pamelor Capsules).

Previous page 1 2 3 4 5 6 7 8 Next page